VASCULAR SOLUTIONS INC 4
4 · VASCULAR SOLUTIONS INC · Filed Aug 3, 2015
Insider Transaction Report
Form 4
Saucedo Jorge
Director
Transactions
- Sale
Common Stock
2015-07-30$37.36/sh−6,039$225,617→ 33,281 total - Exercise/Conversion
Stock Option (Right to Buy)
2015-07-30−10,000→ 0 totalExercise: $9.41Exp: 2017-04-24→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2015-07-30$6.36/sh+10,000$63,600→ 39,320 total - Exercise/Conversion
Common Stock
2015-07-30$9.41/sh+10,000$94,100→ 29,320 total - Sale
Common Stock
2015-07-31$37.30/sh−3,961$147,745→ 29,320 total - Exercise/Conversion
Stock Option (Right to Buy)
2015-07-30−10,000→ 0 totalExercise: $6.36Exp: 2018-04-22→ Common Stock (10,000 underlying)
Holdings
- 10,000
Stock Option (Right to Buy)
Exercise: $9.61Exp: 2020-04-22→ Common Stock (10,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $11.63Exp: 2022-05-04→ Common Stock (10,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $6.39Exp: 2019-04-21→ Common Stock (10,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $11.72Exp: 2021-04-22→ Common Stock (10,000 underlying) - 19,320
Common Stock
Footnotes (3)
- [F1]The price in column 4 is a weighted average price. The price actually received for the stock ranged from $37.25 to $37.50 per share. Dr. Saucedo has provided to the Company and, upon request, will provide any security holder of the Company, or the SEC staff, information regarding the number of shares sold at each price within that range.
- [F2]The price in column 4 is a weighted average price. The price actually received for the stock ranged from $37.25 to $37.32 per share. Dr. Saucedo has provided to the Company and, upon request, will provide any security holder of the Company, or the SEC staff, information regarding the number of shares sold at each price within that range.
- [F3]100% fully vested.